![Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2020/0215/p233-t4.gif)
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP
![Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection](https://connection.asco.org/sites/asco_connection/files/styles/article_image/public/articles/images/JCO-BC-risk-01_747x556.png?itok=cPe2DoDV)
Adding Breast Density and Benign Breast Disease into a Risk Assessment Tool increases Ability to Predict Risk of Breast Cancer | ASCO Connection
![Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2020/0215/p233-t2.gif)
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP
Evaluating clinician acceptability of the prototype CanRisk tool for predicting risk of breast and ovarian cancer: A multi-methods study | PLOS ONE
![Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP](https://www.aafp.org/content/dam/brand/aafp/pubs/afp/issues/2020/0215/p233-t5.gif)
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: Recommendation Statement | AAFP
![Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer Development and pilot of an online, personalized risk assessment tool for a breast cancer precision medicine trial | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00288-8/MediaObjects/41523_2021_288_Fig1_HTML.png)